Melvin L.K. Chua: National Cancer Centre Singapore Brings NPC Expertise to IFHNOS 2026
Melvin L.K. Chua/LinkedIn

Melvin L.K. Chua: National Cancer Centre Singapore Brings NPC Expertise to IFHNOS 2026

Melvin L.K. Chua, Chair of the Department of Head Neck and Thoracic Cancers, shared on LinkedIn:

“D-1

Heading to Brisbane with Gopal Iyer and National Cancer Centre Singapore Team this week for IFHNOS2026 and the HNCIG 2026 Annual Meeting.

Was pleased to be involved in the organising committee. Thanks to Sandro V Porceddu for the invitation to be onboard. Pleased to shape the content for NasopharyngealCarcinoma NPC RadiationOncology
Meeting agenda.

Busy week ahead!

  • 26 Aug: Developing the HNCIG platform for international trials
  • 27 Aug: Radiation Oncology Perspective
  • ⁠28 Aug: Biomarker-directed Treatment in NPC – Ready for Prime Time
  • 28 Aug: NCCS Updates
  • 29 Aug: Concurrent Session: Nasopharyngeal Carcinoma
  • 29 Aug: Case Discussions

Lots to look forward to — interesting science, good discussions and hopefully some time to catch up with old friends along the way.

See everyone in Brisbane!”

Melvin L.K. Chua: National Cancer Centre Singapore Brings NPC Expertise to IFHNOS 2026

Other articles featuring Melvin L.K. Chua on OncoDaily.